Abbott India Ltd

Abbott India Ltd

$ABBOTINDIAPharmaceuticalsNSEBSE

Abbott India Ltd (ABBOTINDIA) last traded at ₹26,414, a market capitalisation of ₹56,129 crore, on a P/E of 34.8. Over the past 52 weeks the stock has ranged between ₹25,150 and ₹32,775. Abbott India Ltd last reported results for the quarter ended Jun 2026, with sales of ₹1,814 crore and net profit of ₹429 crore. Figures are as of 25 Aug 2026 and are not real time.

Abbott India Ltd share price and key metrics

Current price
₹26,414
Market cap
₹56,129 cr
Stock P/E
34.8
Book value
₹2,247
ROE
34.4%
ROCE
44.8%
Dividend yield
1.99%
52w high / low
32775/25150

Metrics as of 25 Aug 2026. Not real time.

Abbott India Ltd quarterly results

In the quarter ended Jun 2026, sales were ₹1,814 cr, up 4.4% from ₹1,738 cr a year earlier. Net profit was ₹429 cr, up 17.2% year on year.

Abbott India Ltd consolidated quarterly results, figures in ₹ crore
₹ croreSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales1,6331,6141,6051,7381,7571,7241,7101,814
Expenses1,1941,1781,1761,2931,2551,2611,2291,291
Operating profit439436429446502463481522
OPM %27%27%27%26%29%27%28%29%
Other income6072767370707675
Interest22468566
Depreciation1818181919191920
Profit before tax479488483493546509531572
Tax %25%26%24%26%24%26%26%25%
Net profit359361367366415376395429
EPS (₹)168.76169.78172.73172.18195.43176.93185.86201.66

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Abbott India Ltd annual results

Abbott India Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales4,3104,9195,3495,8496,4096,9297,004
Operating profit9221,0881,2061,4531,6951,8921,969
OPM %21%22%23%25%26%27%28%
Net profit6917999491,2011,4141,5521,615
EPS (₹)325.04375.87446.80565.30665.64730.39759.88

TTM is the trailing twelve months to the most recent quarter.

Abbott India Ltd growth and returns

Compounded Sales Growth
10 Years
10%
5 Years
10%
3 Years
9%
TTM
6%
Compounded Profit Growth
10 Years
20%
5 Years
17%
3 Years
18%
TTM
11%
Stock Price CAGR
10 Years
19%
5 Years
7%
3 Years
4%
1 Year
-16%
Return on Equity
10 Years
31%
5 Years
34%
3 Years
35%
Last Year
34%

Abbott India Ltd shareholding pattern

Promoters held 74.99% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.38% and DIIs 8.77%.

Abbott India Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters74.99%74.99%74.99%74.99%74.99%74.99%74.99%74.99%
FIIs0.17%0.17%0.16%0.16%0.16%0.19%0.27%0.38%
DIIs9.00%9.01%8.91%9.18%9.11%9.00%8.93%8.77%
Public15.86%15.85%15.94%15.67%15.74%15.83%15.81%15.85%
No. of shareholders69,44967,89269,93467,58471,19975,80175,86678,320

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

Abbott India Ltd corporate filings

  • Voting Results along with Consolidated Scrutinizer''s Report for the 82nd Annual General Meeting held on August 13, 2026.AGM/EGMlow impact
    Filing PDF

    Cruxal's analysis: Abbott India Limited has successfully concluded its 82nd Annual General Meeting held on…

    Read the full analysis
  • Newspaper PublicationCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Abbott India Ltd has fulfilled its regulatory obligation under Regulation 30 of the SEBI…

    Read the full analysis
  • Proceedings of 82nd Annual General Meeting of the Company.AGM/EGMlow impact
    Filing PDF

    Cruxal's analysis: Abbott India Limited successfully concluded its 82nd Annual General Meeting on August 13…

    Read the full analysis
  • Unaudited financial results for the quarter ended June 30, 2026.Resulthigh impact
    Filing PDF

    Cruxal's analysis: Abbott India Limited reported a solid performance for the quarter ended June 30, 2026…

    Read the full analysis
  • Outcome of Board MeetingBoard Meetinghigh impact
    Filing PDF

    Cruxal's analysis: Abbott India Limited reported Q1 FY27 revenue from operations of 1,813.68 crore, marking…

    Read the full analysis
  • Abbott India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Unaudited Financial Results ....Board Meetinglow impact
    Filing PDF

    Cruxal's analysis: Abbott India Limited has announced that its Board of Directors will convene a meeting on…

    Read the full analysis
  • Newspaper Advertisement - Special Window for Transfer and Dematerialization of Physical SecuritiesCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Abbott India Ltd. announced on 2026-08-04 the publication of a newspaper advertisement…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Abbott India Ltd

Cruxal reads every Abbott India Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Abbott India Ltd (ABBOTINDIA) Results, Financials & Share Price | Cruxal